190 related articles for article (PubMed ID: 19414790)
21. Roles of glycans in interactions between gp120 and HIV broadly neutralizing antibodies.
Qi Y; Jo S; Im W
Glycobiology; 2016 Mar; 26(3):251-60. PubMed ID: 26537503
[TBL] [Abstract][Full Text] [Related]
22. Several N-Glycans on the HIV Envelope Glycoprotein gp120 Preferentially Locate Near Disulphide Bridges and Are Required for Efficient Infectivity and Virus Transmission.
Mathys L; Balzarini J
PLoS One; 2015; 10(6):e0130621. PubMed ID: 26121645
[TBL] [Abstract][Full Text] [Related]
23. CD4+ T-lymphocyte lines developed from HIV-1-seropositive patients recognize different epitopes within the V3 loop.
Ratto S; Sitz KV; Scherer AM; Loomis LD; Cox JH; Redfield RR; Birx DL
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Feb; 11(2):128-36. PubMed ID: 8556394
[TBL] [Abstract][Full Text] [Related]
24. Suppression of major histocompatibility complex class II-associated invariant chain enhances the potency of an HIV gp120 DNA vaccine.
Lu X; Wu S; Blackwell CE; Humphreys RE; von Hofe E; Xu M
Immunology; 2007 Feb; 120(2):207-16. PubMed ID: 17116173
[TBL] [Abstract][Full Text] [Related]
25. Class II (I-Ad) restricted T-cell recognition of the V3 loop region of HIV-1 gp120.
Warren AP; Thomas DB
AIDS Res Hum Retroviruses; 1992 May; 8(5):559-64. PubMed ID: 1381202
[TBL] [Abstract][Full Text] [Related]
26. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
[TBL] [Abstract][Full Text] [Related]
27. Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region.
Losman B; Bolmstedt A; Schønning K; Björndal A ; Westin C; Fenyö EM; Olofsson S
AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1067-76. PubMed ID: 11485624
[TBL] [Abstract][Full Text] [Related]
28. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
Schneidman-Duhovny D; Khuri N; Dong GQ; Winter MB; Shifrut E; Friedman N; Craik CS; Pratt KP; Paz P; Aswad F; Sali A
PLoS One; 2018; 13(11):e0206654. PubMed ID: 30399156
[TBL] [Abstract][Full Text] [Related]
29. Synthetic peptides representing discontinuous CD4 binding epitopes of HIV-1 gp120 that induce T cell apoptosis and block cell death induced by gp120.
Howie SE; Cotton GJ; Heslop I; Martin NJ; Harrison DJ; Ramage R
FASEB J; 1998 Aug; 12(11):991-8. PubMed ID: 9707171
[TBL] [Abstract][Full Text] [Related]
30. Humoral immune response to immunocomplexed HIV envelope glycoprotein 120.
Denisova G; Stern B; Raviv D; Zwickel J; Smorodinsky NI; Gershoni JM
AIDS Res Hum Retroviruses; 1996 Jul; 12(10):901-9. PubMed ID: 8798975
[TBL] [Abstract][Full Text] [Related]
31. Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4+ T cell-proliferative responses to glycoprotein 120.
Hioe CE; Jones GJ; Rees AD; Ratto-Kim S; Birx D; Münz C; Gorny MK; Tuen M; Zolla-Pazner S
AIDS Res Hum Retroviruses; 2000 Jun; 16(9):893-905. PubMed ID: 10875615
[TBL] [Abstract][Full Text] [Related]
32. Influence of disulfide-stabilized structure on the specificity of helper T-cell and antibody responses to HIV envelope glycoprotein gp120.
Mirano-Bascos D; Steede NK; Robinson JE; Landry SJ
J Virol; 2010 Apr; 84(7):3303-11. PubMed ID: 20089653
[TBL] [Abstract][Full Text] [Related]
33. Substitutions in a major histocompatibility complex class II-restricted human immunodeficiency virus type 1 gp120 epitope can affect CD4+ T-helper-cell function.
Lekutis C; Letvin NL
J Virol; 1998 Jul; 72(7):5840-4. PubMed ID: 9621044
[TBL] [Abstract][Full Text] [Related]
34. H-2Ld class I molecule protects an HIV N-extended epitope from in vitro trimming by endoplasmic reticulum aminopeptidase associated with antigen processing.
Infantes S; Samino Y; Lorente E; Jiménez M; García R; Del Val M; López D
J Immunol; 2010 Apr; 184(7):3351-5. PubMed ID: 20200278
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha.
Lekutis C; Shiver JW; Liu MA; Letvin NL
J Immunol; 1997 May; 158(9):4471-7. PubMed ID: 9127013
[TBL] [Abstract][Full Text] [Related]
36. Mass spectrometric characterization of a discontinuous epitope of the HIV envelope protein HIV-gp120 recognized by the human monoclonal antibody 1331A.
Hochleitner EO; Gorny MK; Zolla-Pazner S; Tomer KB
J Immunol; 2000 Apr; 164(8):4156-61. PubMed ID: 10754311
[TBL] [Abstract][Full Text] [Related]
37. The orientation of HIV-1 gp120 binding to the CD4 receptor differentially modulates CD4+ T cell activation.
Zimmermann K; Liechti T; Haas A; Rehr M; Trkola A; Günthard HF; Oxenius A
J Immunol; 2015 Jan; 194(2):637-49. PubMed ID: 25472996
[TBL] [Abstract][Full Text] [Related]
38. Conserved N-linked oligosaccharides of the C-terminal portion of human immunodeficiency virus type 1 gp120 and viral susceptibility to neutralizing antibodies.
Hemming A; Gram GJ; Bolmstedt A; Losman B; Hansen JE; Ricksten A; Olofsson S
Arch Virol; 1996; 141(11):2139-51. PubMed ID: 8973529
[TBL] [Abstract][Full Text] [Related]
39. Characterization of host-cell line specific glycosylation profiles of early transmitted/founder HIV-1 gp120 envelope proteins.
Go EP; Liao HX; Alam SM; Hua D; Haynes BF; Desaire H
J Proteome Res; 2013 Mar; 12(3):1223-34. PubMed ID: 23339644
[TBL] [Abstract][Full Text] [Related]
40. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]